FibroGen, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
FGEN Nasdaq 2830 www.fibrogen.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for FibroGen, Inc.

FibroGen Announces 1-for-25 Reverse Stock Split - Jun 12th, 2025 2:02 pm
FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors - Jun 9th, 2025 2:02 pm
Top Asian Dividend Stocks To Consider In June 2025 - Jun 2nd, 2025 10:31 pm
FibroGen First Quarter 2025 Earnings: Beats Expectations - May 16th, 2025 5:58 am
FibroGen Inc (FGEN) Q1 2025 Earnings Call Highlights: Strategic Moves and Cost Management Amid ... - May 13th, 2025 1:10 am
FibroGen (FGEN) Reports Q1 Loss, Tops Revenue Estimates - May 12th, 2025 3:15 pm
FibroGen: Q1 Earnings Snapshot - May 12th, 2025 2:13 pm
FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update - May 12th, 2025 2:02 pm
FibroGen to Report First Quarter 2025 Financial Results - May 5th, 2025 2:05 pm
FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference - Apr 2nd, 2025 2:05 pm
FibroGen Announces Publication of Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer in the Journal of Clinical Oncology - Mar 28th, 2025 5:00 am
FibroGen Full Year 2024 Earnings: Beats Expectations - Mar 19th, 2025 4:22 am
FibroGen Inc (FGEN) Q4 2024 Earnings Call Highlights: Navigating Revenue Declines with ... - Mar 18th, 2025 1:02 am
FibroGen: Q4 Earnings Snapshot - Mar 17th, 2025 2:28 pm
FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results - Mar 17th, 2025 2:05 pm
FibroGen to Report Fourth Quarter and Full Year 2024 Financial Results - Mar 3rd, 2025 2:45 pm
FibroGen sells China unit to AstraZeneca for $160m - Feb 20th, 2025 2:02 pm
FibroGen to Sell China Unit to AstraZeneca for $160 Million - Feb 20th, 2025 6:29 am
AstraZeneca boosts China presence with FibroGen's anemia drug in $160 million deal - Feb 20th, 2025 4:40 am
FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million - Feb 20th, 2025 4:30 am